-1753895472875.webp&w=3840&q=75)
2025 NOSCM | The Complexity of Treatment Options for DLBCL: Novel Antibodies and CAR-T Cell Therapy
0% Complete
Course Overview
Dr. Matthew Lunning discussed DLBCL treatment, highlighting novel antibodies and CAR-T therapy. Future options include Glofit-Pola and next-gen CAR-Ts.
Course Content
This material is non-CME, no credits are available, and a certificate will not be provided upon completion.
Course Details
- Duration
- 0.00 hour
- Released
- Jul 31, 2025
- Last Review
- Jul 31, 2025
- Expires
- Jul 31, 2026
Target Audience
Physicians
Nurses
Pharmacists
Physician Associates
Faculty & Disclosure
Faculty
Matthew Lunning, DO, FACP
Accreditation
NA
%20B-cell%20lymphomas%20(dragged)-1769197425309.webp&w=3840&q=75)
-1769197350402.webp&w=3840&q=75)